维普中文期刊产品整合服务
46篇 您的检索式:作者名="Cursaro"
    题名 作者 年代 出处 被引量
1In vitro effect of thymosin-alphal and interferon-alpha on Thl and Th2 cytokine syn thesis in patients with chronic hepatitis C显示文摘Andreone P Cursaro C Gramenzi A 2001J Viral Hepatitis2001,8,3:1
2Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation显示文摘Scott K. Fung Pietro Andreone Steve H. Han K. Rajender Reddy Arie Regev Emmet B. Keeffe Munira Hussain Carmela Cursaro Pamela Richtmyer Jorge A. Marrero Anna S.F. Lok 2005Journal of Hepatology2005,,6:1
3A randomized controlled trial of thymosin-alphal versus interferon alpha treatment in patients with hepatitis B antigen antibody and hepatitis B virus DNA-positive chronic hepatitis B 显示文摘Andreone P Cursaro C Gramenzi A 1996Hepatology1996,24,4:1
4A randomized controlled trial of thymosin-alpha versus interforon-alpha treatment in patients with hepatitis B e antigen antibody-and hepatitis B virus DNA-positive chronic hepatitis B显示文摘Andreone P Cursaro C Gramenzi A 1996Hepatology1996,24,4:1
5A randomized controlled trial of thymosin-α 1 versus interferon alfa in patients with hepatitis Beantigen antibody and hepatitis B virus DNA-positive chronic hepatitis B显示文摘 Cursaro C Gramenzi A 1996Hepatol1996,24,:1
6Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C 显示文摘Loggi E Cursaro C Scuteri A 2013J Clin Virol2013,56,3:1
7Thymosin- alpha 1 plus interferon-alpha for naive patients with chronic hepa- titis C: results of a randomized controlled pilot trial显示文摘ANDREONE P GRAMENZI A CURSARO C 2004J Viral Hepat2004,1,1:1
8In vitro effect of thymosin-alphal and interferon-alpha on Thl and Th2 cytokine synthesis in patients with chronic hepatitis C 显示文摘 Cursaro C Gramenzi A 2001J Viral Hepatitis2001,8,3:1
9In vitro effect of thymosinalphal and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis显示文摘Andreone P Cursaro C Gramenzi A 2001J Viral Hepat2001,8,3:1
10Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation显示文摘Scott K. Fung Pietro Andreone Steve H. Han K. Rajender Reddy Arie Regev Emmet B. Keeffe Munira Hussain Carmela Cursaro Pamela Richtmyer Jorge A. Marrero Anna S.F. Lok 2005Journal of Hepatology2005,,6:1
11Ketoprofen,peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C:A phaseⅡ study显示文摘AIM:To evaluate the safety of adding ketoprofen to pegylated-interferon(PEG-IFN)with or without ribavirin and the effect on viral kinetics,STAT1 activity and expression of 2'-5'-oligoadenylate synthetase (2'-5'OAS)in genotype 1 chronic hepatitis C in a phaseⅡstudy. METHODS:Forty-five patients were studied:fifteen were randomized to PEG-IFN plus ribavirin(PR),16 to PEGIFN plus ketoprofen and 14 to PR and ketoprofen.Themolecular study of IFN-dependent signal transduction was conducted in 9 patients from each group. RESULTS:The combination of ketoprofen and PEG- IFN with or without ribavirin was safe and well tolerated.An early activation of STAT1 was observed in ke-toprofen-treated patients,but this activation was less sustained over time.Conversely,ketoprofen plus PEG- IFN and ribavirin induced an early and sustained increase of 2'-5'OAS transcription starting 24 h after the first dose until the 36th wk.These data are consistent with the clinical results,showing a better sustained virological response and a lower relapse rate in patients receiving ketoprofen plus PEG-IFN and ribavirin. CONCLUSION:The addition of ketoprofen to the standard therapy of chronic hepatitis C should be explored in larger randomized clinical studies.Annagiulia Gramenzi Carmela Cursaro Marzia Margotti Clara Balsano Alessandra Spaziani Simona Anticoli Elisabetta Loggi Maddalena Salerno Silvia Galli Giuliano Furlini Mauro Bernardi Pietro Andreone 2009World Journal of Gastroenterology2009,15,47:1
12In vitro effect of thymosin-alphal and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C显示文摘Andreone P Cursaro C Gramenzi A 2001J Viral Hepat2001,8,3:1
13Vitamin E as treatment for chronic hepatitis B:results of a randomized controlled pilot trial显示文摘Andreone P Fiorino S Cursaro C 2001Antivir Res2001,49,2:1
14Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C显示文摘Elisabetta Loggi Carmela Cursaro Alessandra Scuteri Elena Grandini Arianna Martello Panno Silvia Galli Giuliano Furlini Mauro Bernardi Claudio Galli Pietro Andreone 2012Journal of Clinical Virology2012,,:1
15In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C显示文摘ANDREONE P CURSARO C GRAMENZI A 2001J Viral Hepat2001,8,:1
16In vitro of thymosin - alphaon Thl and Th2 cytokinesyn the sisinpatients with chronic hepalitisC 显示文摘Vndreone P Cursaro C Gramenzi A 2001J Viral Hepat2001,8,:1
17Randomized controlled trial of thymosin-alphal versus interferon alfa treatment in patients with hepatitis B eantigen antibody-and hepatitis B virus DNA-positive chronic hepatitis B显示文摘Andreone P Cursaro Gramenzi A 1996Hepatology1996,24,4:1
18In vitro effect of thymosinalpha 1 and interferonalpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis显示文摘ANDRENONE P CURSARO C GRAMENZI A 2001J Viral Hepat2001,8,3:1
19High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing lamivudine resistance显示文摘Andreone P Gramenzi A Cursaro C 0,,05:1
20In vitro effect of thymosin-alpha 1 and interferon-alpha on Th1 and Th 2 cytokine synthesis in patients with chro-nic hepatitis C 显示文摘ANDREONE P CURSARO C GRAMENZI A 2001J Viral Hepat2001,8,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费